Viewing Study NCT04572477



Ignite Creation Date: 2024-05-06 @ 3:15 PM
Last Modification Date: 2024-10-26 @ 1:46 PM
Study NCT ID: NCT04572477
Status: RECRUITING
Last Update Posted: 2023-05-06
First Post: 2020-09-29

Brief Title: The Influence of Sequential Tau Protein and Amyloid Plaque Imaging Changes on Stroke Prognosis and Cognitive Outcome
Sponsor: Chang Gung Memorial Hospital
Organization: Chang Gung Memorial Hospital

Study Overview

Official Title: The Influence of Sequential Tau Protein and Amyloid Plaque Imaging Changes on Stroke Prognosis and Cognitive Outcome
Status: RECRUITING
Status Verified Date: 2023-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Amyloid plaques and tau protein are the landmarks of neurodegeneration in Alzheimers disease AD On the other hand it is reported that cerebral ischemia may induce amyloid plaques and tau protein accumulation However it was difficult to in vivo disentangle the complex and dynamic interactions between AD pathophysiology and cerebral vascular injury in the development of post-stroke cognitive impairment in the past With the advent of novel radiotracers specific to cerebral amyloid plaques and tau protein we aim to conduct a prospective multimodal neuroimaging cohort study to investigate the contribution of vascular injury amyloid plaques and tau protein to stroke recovery and post-stroke cognitive impairment
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None